Met Life Investment Management, LLC Novavax Inc Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 81,722 shares of NVAX stock, worth $669,303. This represents 0.01% of its overall portfolio holdings.
Number of Shares
81,722
Previous 81,722
-0.0%
Holding current value
$669,303
Previous $1.03 Million
0.19%
% of portfolio
0.01%
Previous 0.01%
Shares
40 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
95MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.7MShares$129 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$97 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$91.3 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$63 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$48.6 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $641M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...